Cite
Dysregulated signaling pathways in the development of CNTRL-FGFR1-induced myeloid and lymphoid malignancies associated with FGFR1 in human and mouse models.
MLA
Ren, Mingqiang, et al. “Dysregulated Signaling Pathways in the Development of CNTRL-FGFR1-Induced Myeloid and Lymphoid Malignancies Associated with FGFR1 in Human and Mouse Models.” Blood, vol. 122, no. 6, Aug. 2013, pp. 1007–16. EBSCOhost, https://doi.org/10.1182/blood-2013-03-489823.
APA
Ren, M., Qin, H., Kitamura, E., & Cowell, J. K. (2013). Dysregulated signaling pathways in the development of CNTRL-FGFR1-induced myeloid and lymphoid malignancies associated with FGFR1 in human and mouse models. Blood, 122(6), 1007–1016. https://doi.org/10.1182/blood-2013-03-489823
Chicago
Ren, Mingqiang, Haiyan Qin, Eiko Kitamura, and John K Cowell. 2013. “Dysregulated Signaling Pathways in the Development of CNTRL-FGFR1-Induced Myeloid and Lymphoid Malignancies Associated with FGFR1 in Human and Mouse Models.” Blood 122 (6): 1007–16. doi:10.1182/blood-2013-03-489823.